Published in J Nephrol on November 29, 2007
Surveillance and monitoring of dialysis access. Int J Nephrol (2011) 0.84
In search of an optimal bedside screening program for arteriovenous fistula stenosis. Clin J Am Soc Nephrol (2011) 0.83
Diagnostic accuracy of computer tomography angiography and magnetic resonance angiography in the stenosis detection of autologuous hemodialysis access: a meta-analysis. PLoS One (2013) 0.76
Effect of intradialytic change in blood pressure and ultrafiltration volume on the variation in access flow measured by ultrasound dilution. Kidney Res Clin Pract (2012) 0.75
Spiral laminar flow, the earliest predictor for maturation of arteriovenous fistula for hemodialysis access. Indian J Urol (2015) 0.75
Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients. J Thromb Haemost (2012) 2.17
Prospective iterative trial of proteasome inhibitor-based desensitization. Am J Transplant (2015) 1.72
Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int (2006) 1.52
Diagnosis and salvage of an immature fistula. Kidney Int (2007) 1.40
The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol (1996) 1.38
Factors associated with poor outcomes in patients with lupus nephritis. Lupus (2005) 1.30
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc (2005) 1.17
Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss. Am J Transplant (2009) 1.11
Localization of immunoglobulin and complement in pulmonary sarcoid granulomas. Chest (1974) 1.09
A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J Immunol (1997) 1.08
Immunoglobulins in aqueous humour and iris from patients with endogenous uveitis and patients with cataract. Br J Ophthalmol (1973) 1.06
Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Diabetologia (2013) 1.04
Percutaneous transluminal angioplasty for atheromatous renal artery stenosis--blood pressure response and discriminant analysis of outcome predictors. Q J Med (1990) 1.04
Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? Transplantation (1997) 0.99
Prolonged islet allograft acceptance in the absence of interleukin 4 expression. Transpl Immunol (1996) 0.98
Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. Lupus (2013) 0.96
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc (2005) 0.92
IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. J Immunol (1998) 0.92
BRAVO I: A pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access grafts. Kidney Int (2006) 0.87
Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring. Transplant Proc (2002) 0.85
Proteasome inhibition reduces donor-specific antibody levels. Transplant Proc (2009) 0.82
Managing metabolic complications of peritoneal dialysis. Clin Nephrol (2004) 0.81
How to improve dialysis adequacy in patients with vascular access problems. J Vasc Access (2006) 0.81
Elevation of albumin synthesis rates in nephrotic patients measured with [1-13C]leucine. Kidney Int (1992) 0.81
Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis. Transplant Proc (2005) 0.81
Blockade of CD40L/CD40 costimulatory pathway in a DST presensitization model of islet allograft leads to a state of Allo-Ag specific tolerance and permits subsequent engraftment of donor strain islet or heart allografts. Transplant Proc (1999) 0.81
Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection. Transplant Proc (2005) 0.80
Dialysis prescription in elderly hemodialysis patients. J Vasc Access (2007) 0.79
Early and late fistula failure. Clin Nephrol (2008) 0.79
Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allografts. Transplantation (2000) 0.79
Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transplant Proc (2005) 0.79
Factors influencing permanent catheter performance. J Vasc Access (2007) 0.79
Solutions for hemodialysis vascular access dysfunction: thinking out of the box!! J Vasc Access (2006) 0.78
In vitro paclitaxel and radiation effects on the cell types responsible for vascular stenosis: a preliminary analysis. Blood Purif (2006) 0.78
Outcomes of patients with rejection post-polyomavirus nephropathy. Transplant Proc (2005) 0.78
Arteriovenous dialysis access-associated transvenous pacemaker infection. Clin Nephrol (2011) 0.77
Expression of beta 1 integrins in IgA nephropathy. Nephrol Dial Transplant (1997) 0.77
Measurement of hemodynamic and anatomic parameters in a swine arteriovenous fistula model. J Vasc Access (2008) 0.77
African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Transplant Proc (2005) 0.77
ACE inhibitors in the management of haemodialysis ascites. Nephrol Dial Transplant (1994) 0.76
Monoclonal antibodies to cultured human glomerular mesangial cells. I. Reactivity with haematopoietic cells and normal kidney sections. J Pathol (1991) 0.76
Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens. Transplant Proc (2005) 0.76
Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation. Transplant Proc (2005) 0.76
ACE genotype and progression of IgA nephropathy. Lancet (1995) 0.75
Does a selective 5-hydroxytryptamine antagonist (ICI 169, 369) lower blood pressure in hypertensive patients? Br J Clin Pharmacol (1989) 0.75
Nicardipine sustained release in hypertension. Br J Clin Pharmacol (1991) 0.75
ACE inhibitors for myocardial infarction and unstable angina. Lancet (1993) 0.75
Pilot study of early corticosteroid elimination after pancreas transplantation. Transplant Proc (2005) 0.75
The native arteriovenous fistula in 2007. Research needs. J Nephrol (2007) 0.75
Acute renal failure after right nephrectomy for spontaneous rupture and left renal vein ligature. Clin Nephrol (2005) 0.75
Lessons learned. Implementing a vascular access quality improvement program. Part II. Nephrol News Issues (2000) 0.75
How a multidisciplinary vascular access care program enables implementation of the DOQI guidelines. Part I. Nephrol News Issues (2000) 0.75
Renal replacement therapy for hemophiliacs. Int J Artif Organs (1997) 0.75
[Effect of an ambulatory program devoted to chronic renal insufficiency on the reduction of mobidity and hospitalization among patients at the beginning of dialysis treatment]. G Ital Nefrol (2003) 0.75
DOQI guidelines and the vascular access puzzle: finding the pieces that fit. Nephrol News Issues (1998) 0.75
Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplant Proc (2005) 0.75
Prolonged islet allograft acceptance in the absence of expression of interleukin-4. Adv Nephrol Necker Hosp (1997) 0.75
Degradation of sodium 4-dodecylbenzenesulphonate photoinduced by Fe(III) in aqueous solution. Chemosphere (2000) 0.75
[Use of statins for preventing cardiovascular and renal outcomes in patients with chronic kidney disease excluding dialysis: guideline from the Italian Society of Nephrology]. G Ital Nefrol (2007) 0.75
[Disturbances of mineral metabolism and vascular calcifications in dialysis patients (review)]. G Ital Nefrol (2004) 0.75
Establishing a normal baseline for immunohistochemical studies of the kidney. Nephron (1992) 0.75
Renal allograft rejection in a patient with the Wiskott-Aldrich syndrome. Transplantation (1995) 0.75
Vascular access: new approaches needed for a more complex ESRD population. Nephrol News Issues (1997) 0.75
[Antihypertensive agents for the prevention of chronic kidney disease progression: guideline from the Italian Society of Nephrology]. G Ital Nefrol (2007) 0.75
Interventional nephrology: a call to action. Int J Artif Organs (2003) 0.75
Serum ferritin level in hemodialysis patients. Nephron (1996) 0.75
Angiotensin-converting enzyme (ACE) polymorphisms, angiotensin II, ACE inhibitors and glomerulosclerosis--a hypothesis. Nephron (1995) 0.75
[Control of calcium and phosphate metabolism and prevention of vascular calcifications in uremic patients]. G Ital Nefrol (2005) 0.75
Interleukin-15 gene transcripts are present in rejecting islet allografts. Transplant Proc (1997) 0.75
Integrin distribution in normal kidney and cultured human glomerular cells. Exp Nephrol (1995) 0.75